European Journal of Cancer Supplements Citation Rate 2026
1359-6349
eISSN 1878-1217
Elsevier BV
GB
Open Access
About European Journal of Cancer Supplements
European Journal of Cancer Supplements (EJCS) is a peer-reviewed academic journal covering Breast Cancer Treatment Studies and Cancer Treatment and Pharmacology, published by Elsevier BV in GB, catalogued under ISSN 1359-6349 (e-ISSN 1878-1217). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 0.00 — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $3000 USD. OpenAlex records 15,236 works and 18,431 citations, with an h-index of 45.
Submission Tips for European Journal of Cancer Supplements
- Budget $3000 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, Colorectal Cancer Treatments and Studies. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How European Journal of … Compares
Compared against 24 journals in the same research areas.
| ISSN (Print) | 1359-6349 |
|---|---|
| ISSN (Online) | 1878-1217 |
| Publisher | Elsevier BV |
| Country | United Kingdom |
| APC / Cost | $3000 USD |
In-depth profile & metrics
European Journal of Cancer Supplements is published by Elsevier BV and based in United Kingdom. It publishes open access with an article-processing charge of USD 3000.
In our subject taxonomy, European Journal of Cancer Supplements is classified under Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, Colorectal Cancer Treatments and Studies and HER2/EGFR in Cancer Research.
European Journal of Cancer Supplements is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about European Journal of Cancer Supplements
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 0.000 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare European Journal of Cancer Su… against similar publications in its field:
Related Journals in Your Field
-
Drugs Adis, Springer Healthcare IF 9.72
-
Critical Reviews in Oncology/Hematology Elsevier BV IF 4.62
-
Breast Cancer Research BioMed Central IF 4.57
-
Journal of Cancer Research and Clinical Oncology Springer Science+Business Media IF 4.16
-
BMC Cancer BioMed Central IF 3.29
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S13410216
Get weekly updates for Breast Cancer Treatment Studies journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.